Advertisement

Topics

Companies Related to "Neurodyn Cognition" [Most Relevant Company Matches] RSS

14:24 EST 16th February 2019 | BioPortfolio

Here are the most relevant search results for "Neurodyn Cognition" found in our extensive corporate database of over 50,000 company records.

Showing "Neurodyn Cognition" Companies, all 21

Relevant

Neurodyn Cognition Inc.

NCI is a private Canadian biotech company developing Memogain, a patented prodrug of an approved treatment for Alzheimer’s disease, galantamine (Reminyl®). Memogain’s intranasal administration achieves higher dose levels, with significantly greater brain bioavailability, while avoiding the compliance impairing gastro-intestinal adverse effects...


Neurodyn Inc.

Neurodyn Life Sciences Inc.


Cognition Therapeutics Inc.

Cognition Therapeutics, Inc. is a leader in the discovery and development of small molecule therapeutics targeting the toxic proteins that cause the cognitive decline associated with Alzheimer's disease and other degenerative diseases of the human brain. Toxic proteins play a crucial role in a large class of diseases, and there are currently no therapeutics available to prevent or block the destru...

Cambridge Cognition Ltd

Cambridge Cognition Ltd specialises in computerised cognitive testing. Based in Cambridge, England, the company supplies products and services based on CANTAB®, the Cambridge Neuropsychological Test Automated Battery. The cognitive tests in CANTAB are used for neuropsychological assessment in academic research, pharmaceutical clinical trials and healthcare around the world.

MPI Cognition

Savonix

Savonix delivers the world's first fully mobile, evidence-based assessment of cognitive function. Available on Android and iOS for phone and tablet, Savonix Mobile is an accurate, accessible and affordable tool for professional cognitive screening. It empowers healthcare providers, payers and researchers to evaluate and leverage results to improve health a...

Probably Relevant

CogState Ltd

CogState Ltd specializes in the development and commercialization of rapid, computerized tests of cognition (brain function). The tests are sold to pharmaceutical, biotechnology, nutraceutical and functional food companies to quantify the effect of drugs or other interventions on human subjects participating in clinical trials.

Brain Resource

Brain Resource (BRRZY: OTC US, BRC: ASX) translates new findings about the brain into engaging products for consumers, employers and clinicians to improve cognition and brain function. With offices in San Francisco and Australia, and agents in Europe and Israel, the company is underpinned by an international consortium of scientists and clinicians that bri...

Brain Resource, Inc.

Brain Resource, Inc. (BRRZY: OTC US, BRC: ASX) translates new findings about the brain into engaging products for consumers, employers and clinicians to improve cognition and brain function. With offices in San Francisco and Australia, and agents in Europe and Israel, the company is underpinned by an international consortium of scientists and clinicians th...

Delos Living

Delos Living's designs include an array of innovative amenities that research shows will improve various aspects of individual occupant health including: cardiovascular, respiratory and sleep health, orthopedic care, weight and metabolism management, stress and mood management, cognition and memory enhancement, health literacy and health behavior motivation. More information on Delos Living is ava...

Mitochon Pharmaceuticals, Inc.

Mitochon was founded in 2014 with the mission to develop treatments for insidious diseases through the modulation of mitochondrial physiology, with applications to neurodegeneration, neuromuscular, and developmental diseases. Mitochon’s lead programs, MP101 and MP201, specifically harnesses the power of the mitochondria to provide broad neural protect...

Athenagen, Inc

Athenagen, Inc., located in South San Francisco, is engaged in the development of small-molecule drugs that act on the nicotinic acetylcholine (nACh) receptor pathway. The company's lead nACh receptor agonists and antagonists are being developed to treat diseases associated with enhanced or impaired angiogenesis and in diseases where cognitive deficit plays a significant role. Athenagen currently ...

Targacept

Targacept is a clinical-stage biopharmaceutical company that discovers and develops NNR Therapeutics (TM), a new class of drugs for the treatment of central nervous system diseases and disorders. Targacept’s product candidates selectively modulate neuronal nicotinic receptors that serve as key regulators of the nervous system to promote therapeutic effects and limit adverse side effects. Targace...

Neuronascent, Inc

Neuronascent began operations in a fully functional cell culture facility in Maryland. Neuronascent is in the process of developing small-molecule therapeutics for Alzheimer’s disease and depression as the main indications for its “neurogenesis” program. An orally-active, neurogenic agent could promote the formation of new neurons in key areas of the brain, replace damaged neurons, and reduc...

Delos LLC

A U.S.-based real estate developer, Delos® is the pioneer of Wellness Real Estate™, which incorporates amenities that help sustain both the environment and enhance residents' health and well-being. In 2012, Delos introduced the WELL Building Standard™ with President Clinton, the world’s first building standard focused exclusively on enhancing ...

SAM TECHNOLOGY, Inc

SAM TECHNOLOGY, Inc. (SAM) is a privately held neurotechnology R&D lab located in downtown San Francisco. Founded in 1986 by Alan Gevins, an MIT engineer and internationally known neuroscientist, SAM may be unique in its tight interdisciplinary vertical integration of human cognitive neuroscience research and neurotechnology engineering and product development. As documented in 150+ peer-reviewed ...

FORUM Pharmaceuticals Inc.

FORUM Pharmaceuticals Inc. and its subsidiaries (“FORUM Pharmaceuticals” or “FORUM”) are dedicated to developing groundbreaking medicines in support of all those who are affected by or caring for people with serious brain disease, to help them live fuller, more enriching lives. The Company’s robust and diverse pipeline is focused on disco...

The Sync Project

The Sync Project, a PureTech Health company, is developing a platform to scientifically measure and study the effects of music on our health in areas like sleep, cognition, motor coordination and performance. The goal is to collect and correlate real-time biometric data and music, so that we can pinpoint and understand the health properties of music...

Saegis Pharmaceuticals, Inc

Saegis is a development-stage company focused on the discovery of drugs to address behavioral disorders. Saegis has clinically evaluated three small molecule drugs and has a growing pipeline of novel treatments for central nervous system (CNS) diseases involving cognitive dysfunction.The company's focus is on Alzheimer's Disease (AD), Mild Cognitive Impairment (MCI), Cognitive Impairment Associate...

JM NETCREATION LTD

A recent volume of the Annals of the New York Academy of Sciences takes a closer look at how music evolved and how we respond to it. Contributors to the volume believe that animals such as birds, dolphins and whales make sounds analogous to music out of a desire to imitate each other. This ability to learn and imitate sounds is a trait necessary to acquire language and scientists feel that many of...


More From BioPortfolio on "Neurodyn Cognition"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks